August 10, 2021
For Immediate Release
Company name: H.U. Group Holdings, Inc.
Representative: Shigekazu Takeuchi, Director,
President and Group CEO
Securities code: 4544 First Section,
Tokyo Stock Exchange
Contact: Atsuko Murakami,
Executive Officer and CFO
Telephone No.: +81-3-5909-3337
Notice of Revisions to Consolidated Earnings Forecasts for the
First Six-Month and Full-Year Periods of Fiscal Year Ending March 31, 2022
H.U. Group Holdings, Inc. hereby announces that it has revised its first six-month and full-year consolidated earnings forecasts for the fiscal year ending March 31, 2022, announced on May 14, 2021, in light of its recent business performance. Details are as follows.
1. Revisions to consolidated earnings forecasts
(1) Forecasts for first six months of fiscal year ending March 31, 2022 (April 1, 2021 - September 30, 2021)
Profit | ||||||||||||||
Net sales | Operating | Ordinary profit | attributable to | Earnings per | (Reference) | |||||||||
profit | owners of | share | EBITDA* | |||||||||||
(Million yen) | (Million yen) | |||||||||||||
(Million yen) | parent | (Yen) | (Million yen) | |||||||||||
(Million yen) | ||||||||||||||
Previously announced | 121,000 | 17,000 | 18,500 | 12,500 | 219.19 | 23,500 | ||||||||
forecast | (A) | |||||||||||||
Revised forecast | (B) | 128,000 | 21,500 | 21,000 | 13,500 | 236.73 | 28,000 | |||||||
Change | (B - A) | 7,000 | 4,500 | 2,500 | 1,000 | ― | 4,500 | |||||||
Change | (%) | 5.8 | 26.5 | 13.5 | 8.0 | ― | 19.1 | |||||||
(Reference) Results for the | ||||||||||||||
same period a year ago | 98,566 | 8,146 | 7,342 | 5,102 | 89.52 | 14,078 | ||||||||
(First six months of fiscal | ||||||||||||||
year ended March 31, 2021) |
(2) Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2022 (April 1, 2021 to March 31, 2022)
Profit | ||||||||||||||
Net sales | Operating | Ordinary profit | attributable to | Earnings per | (Reference) | |||||||||
profit | owners of | share | EBITDA* | |||||||||||
(Million yen) | (Million yen) | |||||||||||||
(Million yen) | parent | (Yen) | (Million yen) | |||||||||||
(Million yen) | ||||||||||||||
Previously announced | 242,000 | 25,500 | 25,500 | 16,500 | 289.34 | 40,500 | ||||||||
forecast | (A) | |||||||||||||
Revised forecast | (B) | 249,000 | 30,000 | 28,000 | 17,500 | 306.87 | 45,000 | |||||||
Change | (B - A) | 7,000 | 4,500 | 2,500 | 1,000 | ― | 4,500 | |||||||
Change | (%) | 2.9 | 17.6 | 9.8 | 6.1 | ― | 11.1 | |||||||
(Reference) Results for the | ||||||||||||||
previous fiscal year | 223,016 | 25,392 | 25,458 | 17,468 | 306.38 | 37,887 | ||||||||
(Fiscal year ended March 31, | ||||||||||||||
2021) | ||||||||||||||
* EBITDA = Operating profit + Depreciation + Amortization of goodwill |
2. Reasons for revision
The Company has revised its consolidated earnings forecasts as described above, because both net sales and profits for the first six-month and full-year periods of the fiscal year ending March 31, 2022 are expected to exceed the previous forecasts. This chiefly reflects an increase in the number of commissioned PCR tests and greater-than-expected demand for high-sensitivitiy quantitative antigen test reagents due to the recent increase in the number of COVID-19 infections in Japan, as well as increasing COVID-19 testing demands associated with large-scale events held in Japan over the summer.
3. Dividend Forecast
The cash dividend forecast for the fiscal year under review (annual dividend: 125 yen per share) is unchanged from that announced on May 14, 2021.
The earnings forecasts above have been prepared based on information available as of the date on which this material was announced. Actual results may differ due to a variety of factors going forward.
End